{"id":901083,"date":"2025-10-28T09:33:14","date_gmt":"2025-10-28T13:33:14","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/"},"modified":"2025-10-28T09:33:14","modified_gmt":"2025-10-28T13:33:14","slug":"soleno-therapeutics-to-participate-in-upcoming-november-conferences","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/","title":{"rendered":"Soleno Therapeutics to Participate in Upcoming November Conferences"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"left\">REDWOOD CITY, Calif., Oct.  28, 2025  (GLOBE NEWSWIRE) &#8212; Soleno Therapeutics, Inc. (\u201cSoleno\u201d) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will participate in the following investor conferences in November:<\/p>\n<p>\n        <strong>Guggenheim Securities Healthcare Innovation Conference<\/strong><br \/>\n        <br \/>\n        <strong>Presentation Date:<\/strong>\u00a0Tuesday, November 11, 2025\u00a0at\u00a09:00 AM ET<br \/><strong>Presentation Format:<\/strong>\u00a0Fireside Chat<br \/><strong>Webcast: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VgKimpSUO8ntQCmR3Wp070wWRaLku94I9-mYcveshdPm8f8Ni9tkO_THfaB1ZV_AcHx8lho4hkjftfOMclf1Bcae_yme81BlnEI6XnFqcij_z3p5xZt7KVoohVKk9TykL6ZVjblLj4A7FeZVzkPiLA==\" rel=\"nofollow\" target=\"_blank\">Here<\/a><\/p>\n<p>\n        <strong>Stifel 2025 Healthcare Conference<\/strong><br \/>\n        <br \/>\n        <strong>Presentation Date:<\/strong>\u00a0Wednesday, November 12, 2025\u00a0at\u00a08:40 AM ET<br \/><strong>Presentation Format:<\/strong>\u00a0Fireside Chat<br \/><strong>Webcast: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VgKimpSUO8ntQCmR3Wp07_s5GqPI5wpD1GAD_FhsnmfQBCpYDD0yoxnKPitJ5xyuFoxYeHMAGFVapuzM9yfec2Eydv5n8d9b1ieI0f0iEAPQRnOKHqB1lVvbURyb5p87p5u2zOVAm9aO-V51F9XEaAscfGUzxImxhVVgRiMLhlw5HxTgml-lNzEtF7PgXQMt7V3SvBbHdI34ft6acMurZ6jpOkzpI9Bewjvmzl1UdEC4dhp_GcYMT5cY0bKIpdak93izEgJgVAnlOW1ifRMQR0g56gQP3pUjMPIAFnfTYQLu694leDc-jFekGURTtgu11AGbpoNPj0BS1RhYG9hndqX_yyMnXcgEzz2gTofmtoAhv05j5gsyo_iinJGiu12QvEgSsQdNc9jvJheKDR1dJT-vmytfYiAOae_Uh-mAQu5F2kRuDyKRQTJU2qqnSshBxGKfZ0YoGpO9nk1z9UtWtoBQnDICaDHSlUyrwCCqkQo7rUf7M95y2MukrYhJdrGbOxdkbOQnB9H5MTmSTWN53OJhwSDPBTz3P8VBI_U-9CsMUwbp1DFIdEg9x36tjIbfObm66cLwaJxcmwrdAleHrkIasdqBenMCBnPD-QXT2ojvximBTyWheVOIfiuQnZWPURzq6afu8aZOP5v3DrmbFB_gBt3BuhWCCDYwq0neaBRds7SdRt1LCyUS_AsmofI_vjx9Xz2QwrixHCpkSjSHU079wKNELCiNq5XEbiDRSZ7MR8B4hiyyZ5uDrgvBi926pSW0ahjvWk24uGPq77zbDI68v5HmXyaB5s4Na3f509XStf7FmRH3vrefSOzQHoexe6duMPZ6Kj_NGLEXiY8mDamUmWkCF3ZXVC4kMdT52zXgkfEAj6AC4HWGfK7sdLmsrJiunCURdDCxQ3MUpMVxBxIHTEJa4MbN0_HyK3R2siBJCl2E_0Rm68JVdcFbWUGUCKvqHJKWzNIiyIHShZJun1hsAHQXV6i2c7AHtXIXVdmkTtsFNf8IXaC2eaU9wJsFOGvzrfY6yueDwkxNC6sL2W4TwlZgrsXicj_3NPjgJbeWIa9CX4-ew2dnYmMPqfFjPSJAayHtyhQr9TuuNKMcWPYISZ7xgTjDO1pFQLNISZo=\" rel=\"nofollow\" target=\"_blank\">Here<\/a><\/p>\n<p>\n        <strong>Jefferies London Healthcare Conference<\/strong><br \/>\n        <br \/>\n        <strong>Presentation Date:<\/strong>\u00a0Tuesday, November 18, 2025\u00a0at\u00a05:00 PM GMT<br \/><strong>Presentation Format:<\/strong>\u00a0Presentation<br \/><strong>Webcast: <\/strong><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=VgKimpSUO8ntQCmR3Wp07w-8XgtrqkF63XgHmov1YSwRAJ5vRIpcMAbTb7aPMEZ5zHEu1SjB4fvVUWrh4BHTy08h__XBtvKTfl8aeEILladfOIVp3S9Ofg3XC0Th4vZZXKfUij_0eK5SEjYKcWIXeYxyM-cH07-V8hjR1K_qmDVU7zpYKZUsB4VZ_E7EnAXtj5Jqz4fpZGtUELvO31StuZXwHmzKCE-omEtCjKb_Vkc-hSWZ_J2bIeyTuyYfK4a8moS_vM-WRSg7wLxlROBW23V--yznzXjHCteyLzv3iJ5k-acgy1eah5YidrrPHkGL8tK7NA6k9Sj0ePuV7ftQlYf5qvkYrqtNPT3DzQqz7dUSvBbNyjGKfIhDqSmbU-wu6j2RkvhgCw-fAowbBEmsfW8B7__owjIqA7YpNqEFeTIwk2gL1gTdKWGN0I9_0UAQEKrPF8Crrq9j8SYNZ4U3dMs-v0nBcNTRtySXmjb89GoKukwNeR5b-Hh4j1wRVQaLLmmMDahYU9qYgj-vTyC22EaraWqiSO4aNfqpS_IzJl1xChgfG3mr5x32qvipg-Whvb7DRP81YvPNNrdE4pWnFghH0LIFQEglfYlLvrYspwIlpMG4LQfXlsyJ19H0pDLhxsCV1o3hbHGueR47BY45FA==\" rel=\"nofollow\" target=\"_blank\">Here<\/a><\/p>\n<p>Replays of the events will be available in the Investors section on the Company\u2019s website at\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=m0SeZqrrI3yKxgZ378pCpBndeLTbOIwD2HChv9Y9Y0vDhePS_qQph4bVwPaBg6RDQAPqly180CDuOlF-rG2DvQ==\" rel=\"nofollow\" target=\"_blank\">www.soleno.life<\/a>.<\/p>\n<p>\n        <strong>About\u00a0Soleno Therapeutics, Inc.<\/strong>\n      <\/p>\n<p>Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company\u2019s first commercial product, VYKAT XR\u2122\u00a0(diazoxide choline) extended-release tablets, formerly known as DCCR, is a once-daily oral treatment for hyperphagia in adults and children 4 years of age and older with Prader-Willi syndrome. For more information, please visit\u00a0<a href=\"https:\/\/www.globenewswire.com\/Tracker?data=m0SeZqrrI3yKxgZ378pCpJ-khI3rEt2jlOTKy3JX6Ib26QhZA_vASOipIupqUF13fgTitOOmlj7q-G698U56T6xAZd17vLk84D2v0jXfiwKfoD3vHiHcNWrt5Q4ustMwRBrOrx0OmKNtZk2cVDFx8Ht4_i4VfWomH739YSMFG-pt7Y8n6UCb-eyfeClT-qNglde4dxoBZ29M5Fp-3rF-5SHdulg1zNKyiCjtxj0BNGM=\" rel=\"nofollow\" target=\"_blank\">www.soleno.life<\/a>.<\/p>\n<p>\n        <strong>Corporate Contact:<\/strong><br \/>\n        <br \/>Brian Ritchie<br \/>LifeSci Advisors, LLC<br \/>212-915-2578<\/p>\n<p>      <img decoding=\"async\" alt=\"\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU1MTAyOSM3MjExNTg3IzUwMDA3Mjk5OQ==\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" alt=\"\" src=\"https:\/\/ml.globenewswire.com\/media\/ODg1NTlhNTMtY2I2MS00NmYxLWJlOTYtMjg2YmY0M2Y0Yzk0LTUwMDA3Mjk5OS0yMDI1LTEwLTI4LWVu\/tiny\/Soleno-Therapeutics.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>REDWOOD CITY, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) &#8212; Soleno Therapeutics, Inc. (\u201cSoleno\u201d) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will participate in the following investor conferences in November: Guggenheim Securities Healthcare Innovation Conference Presentation Date:\u00a0Tuesday, November 11, 2025\u00a0at\u00a09:00 AM ETPresentation Format:\u00a0Fireside ChatWebcast: Here Stifel 2025 Healthcare Conference Presentation Date:\u00a0Wednesday, November 12, 2025\u00a0at\u00a08:40 AM ETPresentation Format:\u00a0Fireside ChatWebcast: Here Jefferies London Healthcare Conference Presentation Date:\u00a0Tuesday, November 18, 2025\u00a0at\u00a05:00 PM GMTPresentation Format:\u00a0PresentationWebcast: Here Replays of the events will be available in the Investors section on the Company\u2019s website at\u00a0www.soleno.life. About\u00a0Soleno Therapeutics, Inc. Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company\u2019s &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;Soleno Therapeutics to Participate in Upcoming November Conferences&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-901083","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Soleno Therapeutics to Participate in Upcoming November Conferences - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Soleno Therapeutics to Participate in Upcoming November Conferences - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"REDWOOD CITY, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) &#8212; Soleno Therapeutics, Inc. (\u201cSoleno\u201d) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will participate in the following investor conferences in November: Guggenheim Securities Healthcare Innovation Conference Presentation Date:\u00a0Tuesday, November 11, 2025\u00a0at\u00a09:00 AM ETPresentation Format:\u00a0Fireside ChatWebcast: Here Stifel 2025 Healthcare Conference Presentation Date:\u00a0Wednesday, November 12, 2025\u00a0at\u00a08:40 AM ETPresentation Format:\u00a0Fireside ChatWebcast: Here Jefferies London Healthcare Conference Presentation Date:\u00a0Tuesday, November 18, 2025\u00a0at\u00a05:00 PM GMTPresentation Format:\u00a0PresentationWebcast: Here Replays of the events will be available in the Investors section on the Company\u2019s website at\u00a0www.soleno.life. About\u00a0Soleno Therapeutics, Inc. Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company\u2019s &hellip; Continue reading &quot;Soleno Therapeutics to Participate in Upcoming November Conferences&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-28T13:33:14+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU1MTAyOSM3MjExNTg3IzUwMDA3Mjk5OQ==\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"Soleno Therapeutics to Participate in Upcoming November Conferences\",\"datePublished\":\"2025-10-28T13:33:14+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\\\/\"},\"wordCount\":188,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU1MTAyOSM3MjExNTg3IzUwMDA3Mjk5OQ==\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\\\/\",\"name\":\"Soleno Therapeutics to Participate in Upcoming November Conferences - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU1MTAyOSM3MjExNTg3IzUwMDA3Mjk5OQ==\",\"datePublished\":\"2025-10-28T13:33:14+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU1MTAyOSM3MjExNTg3IzUwMDA3Mjk5OQ==\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=OTU1MTAyOSM3MjExNTg3IzUwMDA3Mjk5OQ==\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Soleno Therapeutics to Participate in Upcoming November Conferences\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Soleno Therapeutics to Participate in Upcoming November Conferences - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/","og_locale":"en_US","og_type":"article","og_title":"Soleno Therapeutics to Participate in Upcoming November Conferences - Market Newsdesk","og_description":"REDWOOD CITY, Calif., Oct. 28, 2025 (GLOBE NEWSWIRE) &#8212; Soleno Therapeutics, Inc. (\u201cSoleno\u201d) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will participate in the following investor conferences in November: Guggenheim Securities Healthcare Innovation Conference Presentation Date:\u00a0Tuesday, November 11, 2025\u00a0at\u00a09:00 AM ETPresentation Format:\u00a0Fireside ChatWebcast: Here Stifel 2025 Healthcare Conference Presentation Date:\u00a0Wednesday, November 12, 2025\u00a0at\u00a08:40 AM ETPresentation Format:\u00a0Fireside ChatWebcast: Here Jefferies London Healthcare Conference Presentation Date:\u00a0Tuesday, November 18, 2025\u00a0at\u00a05:00 PM GMTPresentation Format:\u00a0PresentationWebcast: Here Replays of the events will be available in the Investors section on the Company\u2019s website at\u00a0www.soleno.life. About\u00a0Soleno Therapeutics, Inc. Soleno is focused on the development and commercialization of novel therapeutics for the treatment of rare diseases. The company\u2019s &hellip; Continue reading \"Soleno Therapeutics to Participate in Upcoming November Conferences\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/","og_site_name":"Market Newsdesk","article_published_time":"2025-10-28T13:33:14+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU1MTAyOSM3MjExNTg3IzUwMDA3Mjk5OQ==","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"Soleno Therapeutics to Participate in Upcoming November Conferences","datePublished":"2025-10-28T13:33:14+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/"},"wordCount":188,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU1MTAyOSM3MjExNTg3IzUwMDA3Mjk5OQ==","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/","name":"Soleno Therapeutics to Participate in Upcoming November Conferences - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU1MTAyOSM3MjExNTg3IzUwMDA3Mjk5OQ==","datePublished":"2025-10-28T13:33:14+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU1MTAyOSM3MjExNTg3IzUwMDA3Mjk5OQ==","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=OTU1MTAyOSM3MjExNTg3IzUwMDA3Mjk5OQ=="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/soleno-therapeutics-to-participate-in-upcoming-november-conferences\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"Soleno Therapeutics to Participate in Upcoming November Conferences"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/901083","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=901083"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/901083\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=901083"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=901083"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=901083"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}